CESSA Share Price Performance
DKK 18.85
8.63 (84.44%)
Price DKK 18.85
Share Pricen/a
Cessatech A/S Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
CESSA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Cessatech A/S Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -0.53
- 100.00%
- -219.80%
- 0%
About CESSA
- Founded
- 2020
- Employees
- 3
- CEO
- WebsiteView website
Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children. The company also develops CT002, a non-invasive intranasal sedation for children undergoing medical procedures in Phase 2 clinical trials; and CT003, a topical anesthetic in pre-clinical development. The company has a collaboration with University Hospital of Copenhagen, Rigshospitalet, to advance an intravenous formulation of melatonin for post-anaesthesia delirium (CT004) in children. Cessatech A/S was incorporated in 2020 and is based in Copenhagen, Denmark.
